Literature DB >> 384981

Meiges disease: a clinical form of facial convulsion, bilateral and medial.

E S Tolosa, H L Klawans.   

Abstract

In 1910 the French neurologist Henry Meige described in detail a disorder characterized chiefly by symmetric dystonic spasms of the facial muscles, which he called "spasm facial median." Cases with this disorder are rare, and frequently misdiagnosed and inappropriately treated. We report here a translation of Meige's original description of "spasm facial median." We hope that this translation will make it easier to recognize and diagnose this disorder and that it will stimulate greater interest in this unusual syndrome.

Entities:  

Mesh:

Year:  1979        PMID: 384981     DOI: 10.1001/archneur.1979.00500460069010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  Meige's syndrome associated with spasmodic dysphagia.

Authors:  R Kakigi; H Shibasaki; Y Kuroda; T Shin; T Maeyama; S Oono
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

2.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

3.  Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback.

Authors:  P J Brantley; C L Carnrike; M E Faulstich; C A Barkemeyer
Journal:  Biofeedback Self Regul       Date:  1985-06

4.  Meige syndrome: double-blind crossover study of sodium valproate.

Authors:  J W Snoek; T W van Weerden; A W Teelken; W van den Burg; J P Lakke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 5.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

6.  Mental health and quality of life in patients with craniofacial movement disorders: A cross-sectional study.

Authors:  Ming Yi; Jing Li; Gang Liu; Zilin Ou; Yanmei Liu; Jing Li; Yicong Chen; Yaomin Guo; Ying Wang; Weixi Zhang; Jinsheng Zeng; Chao Dang
Journal:  Front Neurol       Date:  2022-09-21       Impact factor: 4.086

Review 7.  Deep Brain Stimulation for the Dystonias: Evidence, Knowledge Gaps, and Practical Considerations.

Authors:  René Reese; Jens Volkmann
Journal:  Mov Disord Clin Pract       Date:  2017-08-12

Review 8.  Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.

Authors:  Travis J W Hassell; David Charles
Journal:  Toxins (Basel)       Date:  2020-04-22       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.